Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 백승연 | * |
dc.contributor.author | 유권 | * |
dc.contributor.author | 김태헌 | * |
dc.contributor.author | 최선영 | * |
dc.contributor.author | 박상희 | * |
dc.contributor.author | 김휘영 | * |
dc.contributor.author | 김민욱 | * |
dc.date.accessioned | 2019-03-27T16:30:08Z | - |
dc.date.available | 2019-03-27T16:30:08Z | - |
dc.date.issued | 2019 | * |
dc.identifier.issn | 1051-0443 | * |
dc.identifier.other | OAK-24491 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/249524 | - |
dc.description.abstract | Purpose: To evaluate efficacy of cone-beam CT–based liver perfusion mapping obtained immediately following conventional transarterial chemoembolization of hepatocellular carcinoma (HCC) for assessing tumor vascularity, technical success of chemoembolization, and treatment response. Materials and Methods: From July 2015 to June 2016, 35 patients with 57 HCCs who underwent cone-beam CT with post-processing software via conventional transarterial chemoembolization for HCC and follow-up examination were included. Three reviewers evaluated technical success on angiography, unenhanced cone-beam CT, contrast-enhanced cone-beam CT, and cone-beam CT–based liver perfusion mapping after transarterial chemoembolization per tumor and per patient. Parenchymal blood volume (PBV) was measured. Treatment response was determined on follow-up CT, MR imaging, or histopathology according to modified Response Evaluation Criteria In Solid Tumors. Diagnostic performance for detection of a viable tumor was evaluated using multiple logistic regression with C-statistics. Results: Treatment response was 38, 17, 2, and 0 for complete response, partial response, stable disease, and progressive disease per tumor and 18, 15, 2, and 0 per patient. In multiple logistic regression, unenhanced cone-beam CT, contrast-enhanced cone-beam CT, cone-beam CT–based liver perfusion mapping, mean value of PBV, and maximum value of PBV of tumor were significant in response assessment for per tumor and per patient (per tumor, all P <.001; per patient, P =.015, P =.001, P <.001, P =.020, and P =.032). Mean value of PBV of tumor was excellent for evaluating technical success with the highest C-statistic (0.880 and 0.920 for per tumor and per patient), followed by that of visual assessment of cone-beam CT–based liver perfusion mapping (0.864 and 0.908). Conclusions: Cone-beam CT–based liver perfusion mapping provided reliable images to evaluate technical success after transarterial chemoembolization of HCC by qualitative visual assessment and quantitative perfusion values. © 2018 SIR | * |
dc.language | English | * |
dc.publisher | Elsevier Inc. | * |
dc.title | The Efficacy of Cone-Beam CT–Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization | * |
dc.type | Article | * |
dc.relation.issue | 3 | * |
dc.relation.volume | 30 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 358 | * |
dc.relation.lastpage | 369 | * |
dc.relation.journaltitle | Journal of Vascular and Interventional Radiology | * |
dc.identifier.doi | 10.1016/j.jvir.2018.10.002 | * |
dc.identifier.wosid | WOS:000460850000014 | * |
dc.identifier.scopusid | 2-s2.0-85061971206 | * |
dc.author.google | Kim K.A. | * |
dc.author.google | Choi S.Y. | * |
dc.author.google | Kim M.U. | * |
dc.author.google | Baek S.Y. | * |
dc.author.google | Park S.H. | * |
dc.author.google | Yoo K. | * |
dc.author.google | Kim T.H. | * |
dc.author.google | Kim H.Y. | * |
dc.contributor.scopusid | 백승연(7201371530) | * |
dc.contributor.scopusid | 유권(7202592827) | * |
dc.contributor.scopusid | 김태헌(57125156300;57219781484) | * |
dc.contributor.scopusid | 최선영(57207282104;55736572600) | * |
dc.contributor.scopusid | 박상희(12041890800) | * |
dc.contributor.scopusid | 김휘영(56493773500) | * |
dc.contributor.scopusid | 김민욱(56122959600) | * |
dc.date.modifydate | 20240429140130 | * |